m30
m30
-
Conclusion M30 is possible to be an indicator of PHC prognosis .
结论M30有可能成为对肝癌预后进行推测的分子标志之一。
-
Forty-six patients ( M30 , F16 ; age 57 ± s11 a ) with coronary heart disease were treated with DI-ao-xin-xue-kang 200 mg po tid for 4-8 wk .
冠心病46例(男性30例,女性16例;年龄57±s11a),口服地奥心血康200mg,tid,治疗4-8wk。采用二维多普勒超声心动图测定左心室功能。